Pharmosa Biopharm Inc.
6875
Rank in Stocks
#19696
Pharmosa Biopharm Inc., a biotechnology firm based in Taiwan, specializes in... Pharmosa Biopharm Inc., a biotechnology firm based in Taiwan, specializes in the development of pharmaceutical products. Its current pipeline includes two key candidates: L606 and L608. L606 is an investigational inhalation/device combination therapy designed to treat both pulmonary arterial hypertension and pulmonary hypertension linked to interstitial lung disease. Similarly, L608 is another inhalation-based therapy, paired with a device, aimed at addressing pulmonary vascular disease. The company, which was established in 2000, originally operated under the name Pharmosa Limited before adopting its current name, Pharmosa Biopharm Inc., in October 2016. Its main offices are located in Taipei City, Taiwan.
Share Price
$0.77125681
Last synced: 2026-11-10
Market Cap
$99.63M
Change (1 day)
0.00%
Change (1 year)
-51.51%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Pharmosa Biopharm Inc. (6875)
Category
Healthcare
Operating Margin for Pharmosa Biopharm Inc. (6875)
Operating Margin as of November 2026 TTM: -762.03%
According to Pharmosa Biopharm Inc.'s latest financial reports, its current operating margin (TTM) is -762.03%. At the end of 2025 the company had an operating margin of -598.88%.
Operating Margin history for Pharmosa Biopharm Inc. from 2019 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | -762.03% | 27.24% |
| 2025 | -598.88% | 359.16% |
| 2024 | -130.43% | 14,392.22% |
| 2023 | -0.90% | 0.00% |
| 2022 | 0.00% | 0.00% |
| 2021 | 0.00% | 0.00% |
| 2020 | 0.00% | 0.00% |
| 2019 | 0.00% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 38.59% | -100.05% |
US
|
|
| -149.01% | -99.80% |
US
|
|
| 25.57% | -100.03% |
AU
|
|
| 31.23% | -100.04% |
BE
|
|
| 29.35% | -100.04% |
NL
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about Pharmosa Biopharm Inc.'s operating margin
What is Pharmosa Biopharm Inc.'s operating margin?
Pharmosa Biopharm Inc.'s operating margin is -762.03%, as of Nov 2026.
What was Pharmosa Biopharm Inc.'s operating margin in 2025?
In 2025, Pharmosa Biopharm Inc.'s operating margin was -598.88%, compared with -130.43% in 2024.
How has Pharmosa Biopharm Inc.'s operating margin changed since 2020?
From 2020 to 2025, Pharmosa Biopharm Inc.'s operating margin was highest in 2022 (0.00%) and lowest in 2025 (-598.88%).
How does Pharmosa Biopharm Inc.'s operating margin compare with similar companies?
Pharmosa Biopharm Inc.'s operating margin (-762.03%) is lower than that of all 5 similar companies listed above. The highest among them is Vertex Pharmaceuticals Incorporated, with 38.59%.